Advert - AstraZeneca - Case AUTH/3769/5/23

• Date posted
  24 October 2024
• Sanction
  Advertisement,
• Case number/s
  AUTH/3769/5/23 - Complainant/Director v AstraZeneca

For failure to comply with the undertaking and assurance given in Case AUTH/3488/3/21, due to the omission of Symbicort (budesonide, formoterol fumarate dihydrate) prescribing information in Case AUTH/3585/11/21, AstraZeneca was ruled in breach of the following clauses of the 2021 Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry
Clause 3.3 - Failing to comply with an undertaking
Clause 5.1 - Failing to maintain high standards